These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
8. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168 [TBL] [Abstract][Full Text] [Related]
9. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Kolodziejczyk B; Duleba AJ; Spaczynski RZ; Pawelczyk L Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473 [TBL] [Abstract][Full Text] [Related]
10. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879 [TBL] [Abstract][Full Text] [Related]
11. Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. Pau CT; Keefe C; Duran J; Welt CK J Clin Endocrinol Metab; 2014 May; 99(5):1870-8. PubMed ID: 24606093 [TBL] [Abstract][Full Text] [Related]
12. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358 [TBL] [Abstract][Full Text] [Related]
13. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495 [TBL] [Abstract][Full Text] [Related]
14. Acute progesterone feedback on gonadotropin secretion is not demonstrably altered in estradiol-pretreated women with polycystic ovary syndrome. Kim SH; Lundgren JA; Patrie JT; Burt Solorzano CM; McCartney CR Physiol Rep; 2022 Apr; 10(7):e15233. PubMed ID: 35384387 [TBL] [Abstract][Full Text] [Related]
15. Progesterone has rapid positive feedback actions on LH release but fails to reduce LH pulse frequency within 12 h in estradiol-pretreated women. Hutchens EG; Ramsey KA; Howard LC; Abshire MY; Patrie JT; McCartney CR Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27535481 [TBL] [Abstract][Full Text] [Related]
16. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Genazzani AD; Battaglia C; Malavasi B; Strucchi C; Tortolani F; Gamba O Fertil Steril; 2004 Jan; 81(1):114-9. PubMed ID: 14711553 [TBL] [Abstract][Full Text] [Related]
17. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. Ibáñez L; Valls C; Ferrer A; Marcos MV; Rodriguez-Hierro F; de Zegher F J Clin Endocrinol Metab; 2001 Aug; 86(8):3595-8. PubMed ID: 11502783 [TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578 [TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome. Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]